Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes Database
This trial is active, not recruiting.
|Condition||hematopoietic stem cell transplantation|
|Sponsor||Center for International Blood and Marrow Transplant Research|
|Collaborator||Medical College of Wisconsin|
|Start date||July 2011|
|End date||October 2014|
|Trial size||390 participants|
|Trial identifier||NCT01353677, 09-SQOL|
This is a multi-institution, non-randomized, prospective pilot study to evaluate the feasibility of collecting quality of life (QOL) data on a large cohort of pediatric and adult allogeneic Hematopoietic stem cell transplantation (HCT) recipients.
|United States||No locations recruiting|
|Other Countries||No locations recruiting|
|Gainesville, FL||University of Florida||no longer recruiting|
|Rochester, MN||Mayo Clinic||no longer recruiting|
|New York, NY||Memorial Sloan-Kettering Cancer Center||no longer recruiting|
|Cincinnati, OH||Cincinnati Children's Hospital Medical Center||no longer recruiting|
|Cleveland, OH||Cleveland Clinic||no longer recruiting|
|Cleveland, OH||University Hospitals of Cleveland||no longer recruiting|
|Seattle, WA||Fred Hutchinson Cancer Research Center||no longer recruiting|
Male or female participants at least 2 years old.
Inclusion Criteria: 1. Adult (≥ 18 years), or pediatric (≥ 2 years and < 18 years) allogeneic HCT recipient (related, unrelated, or CBU) at participating pilot study transplant centers. 2. Signed informed consent form from adult patient or parent/guardian of pediatric patient. 3. Patient must have a valid mailing address within the United States to receive QOL surveys. 4. Ability to speak and read English. 5. Patients with access to a telephone.
|Official title||Pilot Study to Assess the Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes Database|
|Principal investigator||Douglas Rizzo, MD, MS|
|Description||QOL data will be collected at baseline (pre-transplant), 100 days, 6 months, and 12 months post transplant. The transplant center will consent the patient and administer the baseline QOL surveys. The transplants center will then submit the competed baseline data and patient contact information to the Center for International Blood and Marrow Transplant Research (CIBMTR). The remaining surveys will be administered to the patient from the CIBMTR via paper surveys mailed to the patient.|
Call for more information